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a  b  s  t  r  a  c  t
Background  and purpose.  – Decompressive  craniectomy  is the  most  common  justiﬁcation  for  cranioplasty.
A  medico-economial  study  based  on  the  effective  cost  of  the  hydroxyapatite  prosthesis,  the  percentage
of  autologous  bone  graft’s  loss  due  to  bacterial  contamination  and  the  healthcare  reimbursment,  will
allow us  to  deﬁne  the  best  strategy  in term  of  Healthcare  economy  management  for  the  cranioplasties.
A  comparison  was  made  between  the  two groups  of  patients,  autologous  bone  ﬂap  versus  custom-made
prosthesis  in ﬁrst intention,  based  on the  clinical  experience  of  our  department  of  neurosurgery.
Results.  –  No  differences  was  shown  between  the  two groups  of  patients,  in  terms  of  lenght  of  in-hospital
stay  and population’s  characteristics  or medical  codiﬁcation.  The  mean  cost  of  a cranioplasty  using  the
autologous  bone  graft  in  ﬁrst  intention  was D 4045,  while  the use  of  hydroxyapatite  prosthesis  led  to  a
cost  of D  8000  per cranioplasty.
Conclusion.  – In  term  of  Healthcare  expenses,  autologous  bone  ﬂap  should  be used  in  ﬁrst  intention
for  cranioplasties,  unless  the  ﬂap  is  contaminated  or in  speciﬁc  indications,  when the  3D  custom-made
hydroxyapatite  prosthesis  should  be privilegied.






r  é  s  u  m  é
Introduction.  – Les  craniectomies  de décompression  sont  les  principales  indications  secondaires  à  une
cranioplastie.  Une  étude  médico-économique  permettra  d’évaluer  le coût  de la cranioplastie  par  volet
crânien  autologue  ou  par  prothèses  en  première  intention  pour  la réalisation  des  cranioplasties.  Nous
avons  comparé  deux  groupes  de  patients  ayant  eu une  cranioplastie  autologue  ou  un  volet  crânien  sur
mesure,  dans  notre  service  de neurochirurgie.
Résultats.  – Aucune  différence  signiﬁcative  n’a été  mise  en  évidence  entre  les  deux  populations  en terme
de  durée  d’hospitalisation  et  de caractéristiques  de  population.  Le  coût  moyen  d’une  plastie  crânienne
 
Open access under CC BY-NC-ND license.est  de  4045  D en  utilisant  le volet  crânien  autologue  en  première  intention  alors  que  la mise  en place
systématique  d’une  prothèse  en hydroxyapatite  revient  à 8000  D .
Conclusion.  – Il  semble  préférable  en  terme  d’économie  de  santé,  de  reposer  en  première  intention  le
volet  crânien  autologue,  sauf en  cas  de contamination  du  volet  ou dans  des  indications  spéciﬁques,  où
l’on  privilégiera  la  prothèse  en  hydroxyapatite.
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. Introduction
A cranioplasty consist in the replacement of a defective or miss-
ng part of the cranial vault.
The interest of the cranioplasty lies in protecting the brain
gainst injury, for aesthetic purposes, allowing a harmonious
estoration of the cranial vault and treat post craniectomy symp-
oms like headaches.
Nowadays, three different type of cranioplasties are used:
utografts, biomaterials shaped in the operating room and
custom-made” pre-fabricated prosthesis. The autologous cranial
ap is removed during the craniectomy and then re-implanted,
fter storage in patient’s abdominal fat or in a tissue bank. Moldable
rostheses in the operating room are either metallic stents or sur-
ical cements. Finally, since 2008, thanks to technological advances
n radiology and biomaterials, allowing three-dimensional (3D)
econstructions with CT-scan and the discovery of new polymers, it
s now possible to develop “custom-made” devices using 3D recon-
truction of a patient’s skull.
The aim of this retrospective study is to compare the cost
f cranioplasty with autologous cranial ﬂap over the cost of a
ydroxyapatite-made prosthesis for cranioplasty in the context of a
ecompressive craniectomy. Prostheses moldable in the operating
oom being rarely used during decompressive craniectomies due to
he large size of the component, they will not be considered in this
tudy. The allograft and xenograft bone are no longer used, being
ore at risk for infection than the autograft, and less moldable than
he custom prostheses (Moreira-gonzalez et al., 2003).
. Material and methods
This article is a medico-economic study, based on a review
f the literature about the different types of cranioplasty. We
lso conducted a short retrospective study based on the patients
ho underwent a cranioplasty after a decompressive craniectomy,
ospitalized in our department of neurosurgery at the university
ospital of Angers from January 2010 to September 2012.
A collaboration with the central pharmacy of the university hos-
ital of Angers (Dr Martine Urban), and with the tissue bank of the
rench Blood Establishment (EFS) (Dr Marie Splingard), allowed the
ssessment of the actual cost of each of these two techniques of
ranioplasty.
The custom-made prosthesis used in our department is the
ustombone® by Codman®, consisting of porous hydroxyapatite.
his is currently the only prosthesis that is authorized by the French
ational health authority (Haute Autorité de Santé, HAS), dated of
uly 8, 2008, for extensive cranioplasty.
. Results
.1. Description of the population
From January 2010 to September 2012, fourteen patients under-
ent a decompressive craniectomy. Twelve were done for an
xtensive sylvian infarction, ten due to a primary cerebrovascu-
ar stroke, and two following a vasospasm after subarachnoidian
aemorrhage caused by an aneurysm rupture. The two other were
one after a severe brain traumatism, and one after an extended
erebral venous sinus thrombosis.Until the end-date of this study, twelve of these patients under-
ent a cranioplasty, ﬁve with their native bone ﬂap and seven
ith the use of a custom-made hydroxyapatite. The two remaining
atients are waiting for their cranioplasty.urgie 59 (2013) 60–63 61
Both groups were compared. The sex-ratio was the same and
the mean age of 53.6 years ± 6,3 in the autologous group versus
41 years ± 16.7 in the custom-made group, with a p-value of 0.1.
No postoperative complication required the removal of the cran-
ioplasty.
3.2. Mean duration of hospitalisation for the two techniques
For the allograft group, the mean length of postoperative
hospital stay was  of 6.4 ± 0,9 days for the autograft group and
5,71 days ± 1,1 for the custom-made prosthesis group (p = 0,27).
We observed that the mean duration of hospital stay, regardless
of the type of cranioplasty, decreased with the time from seven
days to four days, probably due to the increasing experience of the
surgeons.
3.3. Medical codiﬁcation
For each cranioplasty, the codiﬁcation is similar, using the code
LAMA009 “vault’s cranioplasty” which corresponds to an amount of
D 209. The code LAGA007 is also used sometimes in addition with
the previous code, corresponding to “vault’s cranioplasty removal”
for an amount of D 167.20.
3.4. Cost of the different techniques
For the autologous cranial bone ﬂap, there are two  methods
of preservation of the cranial components: the oldest technique
consists in placing the cranial ﬂap into the patient’s abdominal fat
during the same procedure than the craniectomy. This technique is
less used because of the deformity associated with the presence of
an abdominal scar and the gradual deterioration of the bone ﬂap’s
size and quality. There is also a signiﬁcant risk of subcutaneous
hematoma following the major peeling of the skin needed to insert
the bone graft (Inamasu et al., 2010). The second method, used
nowadays, is the transportation and preservation of the autologous
bone ﬂap in a tissue bank.
The packaging component, consumables, transport containers
and transportation costs are charged D 134.24. Conditioning of the
ﬂap, microbiological controls and blood samples from the patient,
and preservation of the cranial ﬂap are charged D 630.76. Overall,
the storage of the graft is charged D 765 all cost included.
The distribution of the graft, if validated, is charged D 150,
including product traceability, packaging for transport of frozen
graft and transportation costs.
In case of destruction of cranial ﬂap after contamination, there
is no additional billing. The cost of destroying these cranial compo-
nents was estimated by statistical studies and was  included within
conditioning cost, causing no overcharge.
In total, the cost of a sterilized cranial ﬂap autologous, used to
make a cranioplasty is D 915.
If the cranial ﬂap is destroyed due to contamination, support
costs are D 765, corresponding to the storage in tissue bank of the
cranial ﬂap. To this cost we should add the cost of a hydroxyapatite
prosthesis, D 8000, for a total cost of D 8765.
Concerning the custom-made prosthesis, two prosthesis are
delivered for a global cost of D 8000 per patient.
The shape of the prosthesis is calculated to provide a sym-
metrical reconstruction of the cranial vault. After approval by the
neurosurgeon on a prototype of the component and its adjustment
compared to a reconstruction of the skull of the patient, two per-
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. Discussion
.1. Indications of decompressive craniectomy
The main diseases that can lead to a delayed cranioplasty are
rouped into four broad categories. The main providers of cran-
oplasty are decompressive craniectomies performed generally
fter a malignant sylvian ischemic stroke, whose indication has
een codiﬁed by the European Stroke Organization (ESO) in 2008
Servadei, 2011). Another potential vascular indication described is
he cerebral venous sinus thrombosis.
The cranioplasty can be considered in a post-traumatic context
defect of the cranial vault, decompressive cranial ﬂap).
The cranioplasty may  be indicated remotely from an infectious
steitis that resulted in the removal of the bone ﬂap previously
eplaced (Baumeister et al., 2008).
Finally, the cranioplasty may  be proposed following the removal
f a tumor lesion invading the skull.
The usual delay for performing of cranioplasty is 2 to 3 months
fter the acute episode. This delay reduces the risk of infection and
ostoperative morbi-mortality. However, recent studies suggest
hat this period can be shortened safely to less than one month,
ith less complications (Beauchamp et al., 2010).
.2. Medico-economic study: autologous cranial ﬂap versus
custom-made” hydroxyapatite prosthesis as ﬁrst-line
ranioplasty
Data obtained from the tissue bank allowed us to estimate the
ate of skull graft lost due to bacteriological contamination from
0 to 45%, meaning that for four patients out of ten, the use of
 cranioplasty using a hydroxyapatite prosthesis will be needed,
eading to an additional cost for the hospital.
When using an autologous bone graft in ﬁrst intention, the aver-
ge cost of cranioplasty, taking into account a rate of graft loss of
0% is of D 4055 per case. This cost takes into account the cranio-
lasties with autologous cranial ﬂap, of a standard cost of D 915
nd cranioplasties where the autologous bone ﬂap could not be
elocated due to contamination, which therefore required the real-
zation of a hydroxyapatite prosthesis, causing additional costs
765 D + 8000 D ).
The use of the Codman® Custombone® as ﬁrst line implies a
ermanent cost of 8000 D by cranioplasty, due to the price of the
rosthesis.
.3. Comparison to reference
In terms of health cost, it is cheaper to harvest, preserve and
eimplant an autologous cranial ﬂap in ﬁrst line, with an average
ost per cranioplasty 45% lower than the use of a hydroxyapatite-
ade cranial prosthesis. The systematic use of hydroxyapatite in
ranial ﬂap will represent an average additional cost of 3945 D
er cranioplasty. We  decided to calculate the cost of the use of
utologous bone graft replacement in ﬁrst intention taking into
onsideration the graft’s contamination rate and the cost of the
ustom-made prosthesis.
It would become advantageous from an economic standpoint
o use the prosthesis as ﬁrst-line if the rate of loss of bone ﬂaps
xceeded 90%.Taking into account the current rate of bone ﬂap loss, around
0%, the price of the hydroxyapatite prosthesis should be less than
425 D to make it ﬁnancially advantageous to use these prosthesis
n the ﬁrst intention in cranioplasties.urgie 59 (2013) 60–63
4.4. Advantages and inconvenients of the two types of
cranioplasty
The autologous cranial ﬂap is considered as the gold standard for
cranial ﬂap. Biocompatibility is optimal due to the presence of the
patient’s cells in the bone, the lower risk of infection than with any
other type of prosthesis and the low cost of conservation (Artico
et al., 2003). The major drawback of autologous cranial ﬂap is its
method of harvesting, most often made in emergency situations,
by unexperienced people in this task, which results in approxi-
mately 40% of cases of bone ﬂap loss due to contamination during
harvesting or packaging, leading to an over-cost of D 7850 for a
replacement using a custom-made prosthesis.
The advantages of “custom-made” prosthesis consist in provid-
ing a satisfactory cosmetic result and a good biocompatibility due
to the components used. Moreover, hydroxyapatite is recolonized
by osteoblasts from the surrounding skull, allowing ossiﬁcation and
integration of the prosthesis with an excellent stability (Staffa et al.,
2007, 2012). The main drawback of this prosthesis is its price, which
is 8000 D for two  prostheses for the same patient. The prosthesis
being made in biocompatible material, the risk of poor tolerance of
the prosthesis and the risk of infection are low but still higher than
the autologous cranial ﬂap. To achieve a minimum level of resis-
tance, hydroxyapatite prosthesis must be at least 7–8 mm thick,
making its use difﬁcult in areas of low thickness bone defect, as the
temporal bone. It may  be noted that the minimum amount of time
needed for making a “custom-made” prosthesis is quite long, about
1 or 2 months.
4.5. Indications of the custom-made hydroxyapatite prosthesis
The indications for reimbursement of Custombone® are well-
deﬁned in guidelines of the HAS. The marketing authorization was
given for patient with favorable oncologic and neurologic progno-
sis after the failure of an autologous cranial transplant, if the bone
defect is large (more than 35 cm2) or if located in the frontotempo-
ral area (Staffa et al., 2007, 2012).
4.5.1. Perspectives to decrease the cost of cranioplasties
One way to reduce the cost of cranioplasties will be to improve
our sampling methods, sterilization and decontamination of autol-
ogous skull ﬂaps to lower infection rate. It could be possible to soak
the grafts in a solution of antibiotics such as rifamycin, or in an
iodine antiseptic during the time of surgery before their storage
and transportation. It could be advantageous to sterilize the sam-
ples upon arrival at the tissue bank by irradiation or decontaminate
by dipping in successive baths of antibiotics. This could decrease
the rate of loss of cranial ﬂaps, while increasing the overall cost of
conservation of cranial components.
In such protocol, it could be of interest to evaluate the quality
of bone grafts. Adopting such practice may  altogether reduce the
risk of contamination but expose to a detrimental effect on cells
natively present in the graft (Yadla et al., 2011).
Lowering the infection rate may  also be achieved by teaching to
the emergency staff and surgical team the sampling techniques.
Other prostheses are under development and accreditation from
the HAS, as Bioverit®, a vitroceramic alloy that offers an alternative
to the custom-bone (Balossier et al., 2011).Finally, it is very likely that the arrival of new prosthesis will
allow lower prices, making, in the near future, the use of a bio-
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. Conclusion
In terms of overall cost of health, and given the current state of
ur knowledge and ongoing technological developments, the cost
f performing a cranioplasty with autologous cranial ﬂap is less
han that is achieved using a “custom-made” hydroxyapatite pros-
hesis. The ﬁndings of this medico-economic study are similar to
hose made by the report of the Haute Autorité de santé (HAS) of
 July 2011 concerning the marketing authorization of custombone.
he HAS stated that this device has no room in the ﬁrst-line use
f cranioplasties, except in speciﬁc indications, because of its cost
igher than the ﬁrst-line autologous ﬂap.
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